Online Program Home
My Program

Abstract Details

Activity Number: 123
Type: Contributed
Date/Time: Monday, August 1, 2016 : 8:30 AM to 10:20 AM
Sponsor: Section on Statistics in Epidemiology
Abstract #321259
Title: Design Considerations for Vaccine Efficacy Trials in Outbreak Settings
Author(s): Natalie Dean* and M Elizabeth Halloran and Ira Longini
Companies: University of Florida and Fred Hutchinson Cancer Research Center and University of Florida
Keywords: vaccine ; infectious disease ; outbreak ; Ebola ; efficacy trial
Abstract:

Evaluating the efficacy of a vaccine during a public health emergency presents important logistical challenges. The novel ring vaccination cluster randomized trial design, in which a cluster is defined as the contacts and contacts of contacts of an index case, addressed many of these challenges and was successfully used in Guinea in 2015 to evaluate an Ebola vaccine candidate. One key statistical consideration of this and other vaccine trial designs is determining which cases should contribute to the primary vaccine efficacy outcome. Cases appearing shortly after vaccination may have been infected prior to vaccination or before developing protective immunity. The traditional strategy is to start counting cases after a long fixed, delay period, but this may require dropping a large proportion of the cases observed in the trial. Furthermore, if incidence declines over time within clusters, it may be hard to collect enough countable endpoints. We use an analytical and simulation based framework to provide recommendations on how to select the optimal delay period to maximize study power for the primary vaccine efficacy outcome.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association